Colorectal Cancer Clinical Trials
Colorectal Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for colorectal Cancer. Corterve aggregates actively recruiting Colorectal Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Colorectal Cancer studies
- Lead-212 PSV359 Therapy for Patients With Solid TumorsNCT06710756PHASE1, PHASE2Perspective TherapeuticsPancreatic Ductal AdenocarcinomaLos Angeles, California
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal HistologiesNCT04847063PHASE1National Cancer Institute (NCI)Peritoneal MesotheliomaBethesda, Maryland
- FOG-001 in Locally Advanced or Metastatic Solid TumorsNCT05919264PHASE1, PHASE2Parabilis Medicines, Inc.CancerPhoenix, Arizona
- Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology PatientsNCT07403981NAStanford UniversityColorectal CancerPalo Alto, California
- 5-Fluorouracil/Leucovorin (5FU/LV) in Combination With Regorafenib in Patients With Metastatic Colorectal CancerNCT06887218PHASE2The Methodist Hospital Research InstituteMetastatic Colorectal Cancer (CRC)Houston, Texas
- A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)NCT06428409PHASE1, PHASE2Merck Sharp & Dohme LLCColorectal CancerLos Angeles, California
- A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerNCT07525206PHASE3AbbVieColorectal CancerGoodyear, Arizona
- Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)NCT07702032PHASE3GenmabLeft-sided Colorectal CancerHot Springs, Arkansas
- A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal CancerNCT06820463PHASE2AbbVieMetastatic Colorectal CancerDuarte, California
- Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerNCT07228832PHASE3Summit TherapeuticsMetastatic Colorectal Cancer (CRC)Mobile, Alabama
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsNCT00001823National Cancer Institute (NCI)Synovial Cell CancerBethesda, Maryland
- Molecular Basis for Variations in Hereditary Colorectal Cancer SyndromesNCT02863172M.D. Anderson Cancer CenterHereditary Colorectal Cancer SyndromeHouston, Texas
Colorectal Cancer trials by state
Colorectal Cancer trials by metro
Frequently asked questions
- How do I find recruiting Colorectal Cancer clinical trials?
- Browse the actively recruiting Colorectal Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Colorectal Cancer clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Colorectal Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.